Pencil beam scanning proton lattice radiotherapy: single-field versus multi-field optimization

Read full text
Authors: Shouyi Wei, Lee Xu, Hang Qi, Ajay Zheng, Milo Vermeulen, Annemarie F. Shepherd, K. Alektiar, Nancy Y. Lee, Richard Bakst, C. Guha, Pingfang Tsai, Minglei Kang
+6 more Xiaodong Wu, Irini Yacoub, Jehee Isabelle Choi, Arpit Chhabra, Charles B. Simone, Haibo Lin
Cited by: 2
References: 31

Abstract

Objective: To evaluate the advantages and disadvantages of single-field versus multi-field optimization in the clinical implementation of pencil beam scanning (PBS) proton lattice radiotherapy (LRT). Methods: LRT proton plans were created retrospectively for 12 patients with head-and-neck, thoracic, or abdominal bulky tumors, averaging a gross tumor volume (GTV) of 1011.1 cc (between 333 cc and 3546 cc). The plans were developed in the RayStation treatment planning system (version 2023B), adhering to established consensus guidelines for prescription dose and planning goals. For each plan, 6-8 vertices with an average diameter of 1.4 cm were positioned approximately 3.5 cm apart. The prescription was 18 Gy to each vertex and 3 Gy to the GTV. Single-field optimization (SFO) and multi-field optimization (MFO) techniques were employed. The dosimetric parameters of GTV Dmean, D95%, generalized equivalent uniform dose (gEUD a=-10), vertex D90%, peak-to-valley dose ratio (PVDR), and skin D1% were used for plan quality assessment. Plan robustness was also investigated by comparing dose metrics between the nominal and second worst-case scenarios in the robust analysis. Results: For all 12 patients, both SFO and MFO plans achieved a PVDR close to 4 across the three treatment sites. No significant differences in primary dose metrics were observed between SFO and MFO plans, except for skin D1%, which was reduced by an average of 25% in the MFO plans (p

Fields of Study & Subjects

Radiation Therapy and Dosimetry Advanced Radiotherapy Techniques Boron Compounds in Chemistry

Publication details

Journal / source
Frontiers in Oncology
Publisher
Frontiers Media SA
Volume
15
Pages
1716722–1716722
Publication date
20 January 2026
Language
EN